A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response Jason W.-L. EngKathleen M. KokolusElizabeth A. Repasky Review 12 October 2014 Pages: 1115 - 1128
Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours Anna St. SwierzkoAgnieszka SzalaMaciej Cedzynski Original Article Open access 20 July 2014 Pages: 1129 - 1140
AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and prediction Sonia A. PerezEleftheria A. AnastasopoulouConstantin N. Baxevanis Original Article 23 July 2014 Pages: 1141 - 1150
Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation Tim LuetkensSebastian KoboldDjordje Atanackovic Original Article 31 July 2014 Pages: 1151 - 1162
A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control Jennifer D. StoneDaniel T. HarrisDavid M. Kranz Original Article 01 August 2014 Pages: 1163 - 1176
Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer Manja IdornTania KøllgaardPer thor Straten Original Article 02 August 2014 Pages: 1177 - 1187
FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4+ T regulatory cells Walter Moises Tobias BragaBruna Raphaeli da SilvaGisele Wally Braga Colleoni Original Article Open access 07 August 2014 Pages: 1189 - 1197
Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining Lindsey ChudleyKaty J. McCannChristian H. Ottensmeier Original Article Open access 19 August 2014 Pages: 1199 - 1211
CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma Britnie R. JamesKristin G. AndersonThomas S. Griffith Original Article 21 August 2014 Pages: 1213 - 1227
Fast-growing in-transit melanoma metastasis after intratumoral interleukin-2 David Moreno-RamírezMartina Alés-MartínezLara Ferrándiz Letter to the Editors 24 July 2014 Pages: 1229 - 1230
Limited efficacy of intratumoral IL-2 applied to large melanoma metastases Benjamin WeideThomas Kurt EigentlerClaus Garbe Letter to the Editors 24 July 2014 Pages: 1231 - 1232
Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma Ester SimeoneGiusy GentilcorePaolo A. Ascierto Erratum 25 September 2014 Pages: 1233 - 1233
